VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly FCF Margin came in at 24.0% in Q2 2026, down 53.0% YoY from 51.06% in Q2 2025, and up 288.42% on a QoQ basis from 12.74% in Q1 2026.
VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 7 years of FCF Margin data on file, last reported at 24.0% in Q2 2026.
- Quarterly FCF Margin fell 53.0% year-over-year to 24.0% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 26.92% (up 1968.0% YoY) and the FY2026 annual result came in at 26.92%, up 1968.0% from the prior year.
- FCF Margin grew to 24.0% in Q2 2026, from 12.74% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 253.91% in Q3 2025 to a low of 576.85% in Q1 2024.
- A 5-year average of 58.7% and a median of 10.24% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin slumped 29924 bps — and 2025, when it jumped 71853 bps.
- Tracing VNOV's FCF Margin over 5 years: stood at 53.06% in 2022, then sank by 244 bps to 76.17% in 2023, then surged by 104 bps to 3.0% in 2024, then soared by 1560 bps to 49.79% in 2025, then plunged by 52 bps to 24.0% in 2026.
- The last three FCF Margin figures came in at 24.0% (Q2 2026), 12.74% (Q1 2026), and 49.79% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | -0.32% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 2.86% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 2.24% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 6.13% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -29.43% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -7.05% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -3.87% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -9.39% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 24.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 24.00% |
| Jan 31, 2026 | -12.74% |
| Oct 31, 2025 | 49.79% |
| Jul 31, 2025 | 253.91% |
| Apr 30, 2025 | 24.53% |
| Jan 31, 2025 | 67.75% |
| Oct 31, 2024 | 3.00% |
| Jul 31, 2024 | -464.62% |
| Apr 30, 2024 | -35.11% |
| Jan 31, 2024 | -576.85% |
| Apr 30, 2023 | -76.17% |
| Jan 31, 2023 | -281.77% |
| Oct 31, 2022 | 53.06% |
| Jul 31, 2022 | 45.21% |
| Apr 30, 2022 | -30.74% |
| Jan 31, 2022 | 17.47% |
| Oct 31, 2021 | 43.54% |
| Jul 31, 2017 | 34.09% |